I really want to find reasons to be optimistic, but it's hard; I can't find any. On an individual level, we can all keep trying, but looking at the macro picture for a generation, it's truly difficult. If possible, the S&P 500 remains the best choice. A heavy sigh...
Long image$XTALPI(02228.HK) Chinese concept stocks are being sold off to pay taxes. This could be a key factor.
Repost:
Bloomberg reports: Offshore trust taxation - The final ultimatum has been issued, but almost no one is reporting.
The State Taxation Administration issued a "final reminder" just three days before the Oct 22 grace period expires, yet very few people have actually filed.
On Monday, Oct 19, the STA posted a reminder on its official website, urging relevant taxpayers to review their offshore trust arrangements and file taxes in accordance with the law by Oct 22, "to avoid late fees and other related risks." In the preceding months, local tax bureaus had already sent notices and SMS messages through various channels for three months. While the wording remained soft ("reminder," "helping taxpayers fulfill their legal obligations"), the timing combined with the mention of "late fees" effectively amounts to a final ultimatum.
An asset management industry insider, speaking anonymously, said: "Many mainland clients have come to us for consultations recently, but very few have actually completed the filing process. 'We do advise our clients to file, but they often choose to wait and see, or simply don't file at all. Ultimately, whether to file is the client's own decision.'"
Oct 22 is not the end, but a watershed moment for enforcement.
$XTALPI(02228.HK) Good news? Or bad news?
Anthropic has also entered the drug discovery space. The team behind writing prompts for Claude turns out to be Citrini Research, previously well-known in the semiconductor and AI sectors.
- After running for 64 hours, computational power generated 318,000 scorpion venom-binding proteins
- 211 candidates were selected; AI drafted emails to place orders with Twist Bioscience for synthesis
- Wet lab validation: 17 showed binding capability
318,000 designs, 211 advanced to the lab, 17 passed.
OpenAI: Acquired Orchestra to act as "project managers" at pharma companies overseeing schedules;
Anthropic: Letting AI generate its own questions and place orders directly, while leaving testing to the labs.
$XL2CSOPHYNIX(07709.HK)$XTALPI(02228.HK)Recently, a major takeaway for me has been: how significant is the fundamental picture in the face of liquidity? Before prices revert, can you distinguish whether it's a value issue or a liquidity issue?
$XL2CSOPHYNIX(07709.HK) There must be a major liquidity issue in Korea. A market without leverage has no future, while one with excessive leverage becomes too crowded. As for the current situation in Korea? I can only remain silent and pray.
$XL2CSOPHYNIX(07709.HK)What about the short selling data? Is it expected to be brutal?
$XL2CSOPHYNIX(07709.HK)The happiness of suffering together. This is a deliberately added leveraged position. Let's hold it for a month and see how things go.
$XL2CSOPHYNIX(07709.HK) Awkward, tried too hard to show off, hmm, what to do?
$Tesla(TSLA.US) My eldest daughter just turned 18 and entered the stock market to support Longbridge trading. Click-clack, she's actually in the green across the board. Damn it, I wish her all the best.
$XTALPI(02228.HK) XtalPi needs to find a new path; it must develop its own pipeline! It must develop its own pipeline! It must bring forth its own innovative drugs!
$XL2CSOPHYNIX(07709.HK) added a position of 8,000 shares at 33.8 today; currently holding: 19,800 shares. Stage cost: 36.88
$XTALPI(02228.HK) A sigh, it's truly bitter. Let me think... let me think again about whether to cut myself off with one stroke 🙂
$XL2CSOPHYNIX(07709.HK) The distance to a pullback isn't too far. In principle, the profitability of storage companies remains very strong. It's just that market divergence is significant. Yesterday in Singapore, I discussed this topic with a friend who does macro trading. One idea came up: the reason for such wide divergence right now is concern over the growth rate and sustainability of AI-driven earnings. Is there a hidden issue behind this? Currently, enterprises (and their owners) struggle to effectively measure the "value-add" brought by AI adoption. For instance, you use AI—you've created how much new value? Saved how much cost? You might feel you can't live without it and love Claude or ChatGPT, but what is its actual monetary value? This problem is even more complex for enterprises. It will take some time for at least some companies and owners to figure this out. This is also an issue the industry needs to ponder.
$XL2CSOPHYNIX(07709.HK)阶段性 buying sufficient. The positions that were previously cleared have returned.
$XTALPI(02228.HK)Currently, this is most likely an effect stemming from the biotech crash in US stocks last night.
$XTALPI(02228.HK) The day after tomorrow on 10.9 a year ago, it seemed to dump the market like this too. As far as I remember. But the price level was higher back then. Is it dumping two days earlier this year? Sigh... this liquidity.
$XTALPI(02228.HK) What's going on? Is this crazy?
$Recursion Pharmaceuticals(RXRX.US) Pre-market looks good, sentiment remains warm. Short-term breakout above $5 seems likely. If it holds above $5.2, would that break almost all technical resistance? Things are looking up. Fingers crossed.
$Rocket Lab(RKLB.US) A pre-market trap? Or is it really rallying? We'll see in October!
$XL2CSOPHYNIX(07709.HK) has reached the water level at close 😄. Continuing to oscillate within the range, the core issue is excessive divergence.
$XTALPI(02228.HK) Congrats to the bosses who kept holding, stay steady
